Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

NCT00092625 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

442

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Coronary Disease

Interventions

DRUG: MK0653, ezetimibe
DRUG: Comparator: ezetimibe, placebo

Sponsor

Organon and Co